tiprankstipranks

Karin Walker Insider Profile

4 Followers
Karin Walker, CAO at Prothena, holds 0.00 shares in Prothena (Ticker: PRTA), holds 40.60K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds 0.00 shares in Affymax (Ticker: AFFY). Most recently, Karin Walker Bought ― shares of Prothena on Jan 24, 2024 for an estimated value of 67.65K.
tipranks
Karin Walker

Karin Walker
Prothena (PRTA)
CAO

Ranked #68,784 out of 99,024 Corporate Insiders

Profitable Transactions

30%
8 out of 27 Profitable Transactions

Average Return

-4.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$91K
100.00%
0.00%
0.00%
A breakdown of Karin Walker's holdings

Insider Roles

Cyclacel Pharmaceuticals
(CYCC)
Director
Prothena
(PRTA)
CAO
Affymax
(AFFY)
VP, Finance & CAO
Roles that Karin Walker holds in companies

Most Profitable Insider Trade

Stock:
Prothena
(PRTA)
Rating:Informative Buy
Date:Dec 11, 2014 - Dec 11, 2015
Return:+260.30%
The most profitable trade made by Karin Walker

Karin Walker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Prothena
Jan 24, 2024
CAO
Informative Buy
67.65K
$0.00
Cyclacel Pharmaceuticals
Jul 03, 2023
Director
Uninformative Buy
$91.35K
Affymax
VP, Finance & CAO
$0.00
List of latest transactions for each holding click on a transaction to see Karin Walker's performance on stock

Karin Walker insider profile FAQ

What is the percentage of profitable transactions made by Karin Walker?
The percentage of profitable transactions made by Karin Walker is 30%.
    What is the average return per transaction made by Karin Walker?
    The average return per transaction made by Karin Walker is -4.30%.
      What stocks does Karin Walker hold?
      Karin Walker holds: PRTA, CYCC, AFFY stocks.
        What was Karin Walker’s latest transaction?
        Karin Walker latest transaction was an Informative Buy of $67.65K.
          What was Karin Walker's most profitable transaction?
          Karin Walker’s most profitable transaction was an Informative Buy of PRTA stock on December 11, 2014. The return on the trade was 260.30%.
            What is Karin Walker's role in Prothena?
            Karin Walker's role in Prothena is CAO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.